近日，海南博鳌乐城首届全球创新药械博览会在海南博鳌乐城先行区举行。本届博览会为期两天， 以"智汇全球创新技术，共筑人类健康未来"为主题，汇聚了来自国内外的政府代表、医疗机构、科研院 所、高校专家及企业代表，旨在搭建全球医疗科技交流合作平台，开展全球创新药械及医疗技术研发趋 势与临床应用研讨，深化药械研发、生产、流通全链条协同合作，推动国际前沿医疗资源汇聚与落地。 琼海市乐城管理局局长傅晟在开幕式上作"乐城在全球创新药械引进的实践"主题分享，详细介绍了乐城 先行区从"政策高地"迈向"产业高地"的实践历程，他表示，当前乐城走出了一条特许药械"引进来、用 得好、推出去"的特色之路，构建起国际创新药械全链条生态体系，并现场发布了《海南博鳌乐城国际 医疗旅游先行区国际创新药械引进及使用白皮书》。该白皮书展示了乐城百余款已落地创新产品的引进 成果与真实案例，勾勒出从特许引进、真实世界数据应用到产业化发展的完整生态链，为全球产业界提 供了一份洞察中国医疗创新市场的创新指南。 琼海市委书记、乐城管理局党委书记周长强表示，首届全球创新药械博览会的举办，是乐城扩大高水平 对外开放、加速全球医疗科技创新成果转化的重要举措，致力于构 ...

Core Insights - The National Medical Products Administration (NMPA) is focusing on enhancing the innovation and development of medical devices in Hainan, leveraging the advantages of the Hainan Free Trade Port policy [1] Group 1: Policy and Regulatory Focus - The NMPA emphasizes the importance of policy guidance and proactive services to bridge the gap between clinical needs and enterprise research and development [1] - There is a commitment to advancing regulatory science and deepening real-world research, which includes refining data collection standards and application rules [1] Group 2: Industry Engagement - The NMPA is actively engaging with various institutions, including Hainan University and Sichuan University, to understand the local medical device innovation landscape [1] - Participation in the Fourth Boao International Medical Device Real-World Research Conference indicates a strategic approach to fostering collaboration and knowledge sharing within the industry [1]

Core Insights - The Hainan Boao Lecheng International Medical Tourism Pilot Zone is transitioning from a "policy testing ground" to an "industrial highland" with the establishment of the Hainan International Innovative Drug and Medical Device "Three Medical Collaboration" Trusted Data Space [1][4] Group 1: Development and Achievements - The Hainan International Innovative Drug and Medical Device Trusted Data Space has been approved as a national pilot for industry trusted data space innovation, making it the only pilot in the health sector nationwide [3] - Over the past decade, the Lecheng Pilot Zone has introduced more than 510 innovative drugs and medical devices globally, collaborating with over 180 companies from 20 countries [4] - The application of real-world data in drug and medical device registration has reduced the average domestic listing time for global innovative products by 1.5 years [4] Group 2: Future Plans and Goals - The Lecheng Pilot Zone aims to enhance the integrity and application value of real-world data by addressing technical and institutional challenges in medical data circulation [3][4] - The initiative will focus on creating a data-driven ecosystem that integrates drug and medical device research, medical services, and healthcare regulation [5] - The goal is to establish the trusted data space as an incubator for innovation in the healthcare industry, promoting cross-border clinical research and international telemedicine [5]

Core Insights - The 2025 West China Health Industry Ecological Conference was held in Boao, Hainan, showcasing the region as a national-level pilot zone for healthcare reform and innovation [1][2] - Boao Lecheng has implemented over 500 international innovative drugs and devices, benefiting more than 160,000 patients, and has pioneered clinical applications of cutting-edge biomedical technologies [1] - The region has established itself as a hub for global medical innovation, attracting leading companies and forming a clinical research cluster [2] Group 1 - Boao Lecheng is recognized as the only medical special zone in China, enjoying the most open innovation policies, including special permissions for medical research and international medical exchanges [1] - The region has successfully launched 8 innovative projects and is the first in China to apply real-world data in clinical trials, accelerating the registration of 21 international innovative drugs and devices [1] - Boao Lecheng has created a model combining real-world data with medical insurance access, facilitating the inclusion of 3 innovative products in the national medical insurance catalog [1] Group 2 - The region serves as an open hub for global medical resources, fostering deep connections between top medical institutions, research institutes, and biopharmaceutical companies [2] - Boao Lecheng has attracted over 30 medical institutions and established a global cooperation network to support Chinese enterprises in expanding internationally while inviting foreign partners [2] - The region aims to be a highland for the convergence and integration of innovative elements in the biopharmaceutical industry [2]